CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells

Background/Aims: Metastasis is the major cause of death in patients with osteosarcoma. There is an urgent need to identify molecular markers that promote metastasis. Cluster of differentiation 44 is a receptor for hyaluronic acid (HA) and HA-binding has been proven to participate in various biologic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Tang Liu, Zuyun Yan, Yong Liu, Edwin Choy, Francis J. Hornicek, Henry Mankin, Zhenfeng Duan
Formato: Artigo
Idioma:Inglês
Publicado: Cell Physiol Biochem Press GmbH & Co KG 2018-04-01
Series:Cellular Physiology and Biochemistry
Assuntos:
Osteosarcoma
CRISPR-Cas9
Meta-analysis
CD44
Metastases
Gene therapy
Acceso en liña:https://www.karger.com/Article/FullText/489072
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares